0001415889-24-001598.txt : 20240119
0001415889-24-001598.hdr.sgml : 20240119
20240119162505
ACCESSION NUMBER: 0001415889-24-001598
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240118
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fischer Seth H. Z.
CENTRAL INDEX KEY: 0001573553
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36576
FILM NUMBER: 24545919
MAIL ADDRESS:
STREET 1: C/O TRIUS THERAPEUTICS, INC.
STREET 2: 6310 NANCY RIDGE DRIVE, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER NAME:
FORMER CONFORMED NAME: Fischer Seth H.Z.
DATE OF NAME CHANGE: 20130402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARINUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001267813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 RADNOR CORPORATE CENTER SUITE 500
STREET 2: 100 MATSONFORD RD
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-801-4670
MAIL ADDRESS:
STREET 1: 5 RADNOR CORPORATE CENTER SUITE 500
STREET 2: 100 MATSONFORD RD
CITY: RADNOR
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: MARINUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031022
4
1
form4-01192024_090158.xml
X0508
4
2024-01-18
0001267813
MARINUS PHARMACEUTICALS, INC.
MRNS
0001573553
Fischer Seth H. Z.
5 RADNOR CORPORATE CENTER, SUITE 500
100 MATSONFORD RD
RADNOR
PA
19087
true
false
false
false
0
Common Stock
2024-01-18
4
A
0
4600
0
A
10626
D
Stock Option (Right to Buy)
9.74
2024-01-18
4
A
0
20900
0
A
2034-01-18
Common Stock
20900
20900
D
Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 18, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
The option vests and becomes exercisable in 12 equal monthly installments beginning on February 18, 2024, subject to the reporting person's continued service with the Issuer.
/s/ Debra A. Mohollen, Attorney-in-Fact
2024-01-19